| Firm | Analyst | Telephone | |
|---|---|---|---|
| EF Hutton | Michael King | mking@efhuttongroup.com | |
| ThinkEquity | Ashok Kumar | 646.968.9363 | ak@think-equity.com |
| Zacks Research | John Vandermosten, CFA | 312.265.9588 | vandermosten@zacks.com |
Lantern Pharma Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Lantern Pharma Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Lantern Pharma Inc. or its management. Lantern Pharma Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.
